QSS
BPMC

Quantitative Systematic Strategies’s Blueprint Medicines BPMC Stock Holding History

Quantitative Systematic Strategies’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,990
Closed -$527K – 65
2021
Q2 		$527K Sell
5,990
-6,853
-53% -$628K 0.18% 224
2021
Q1 		$1.25M Buy
12,843
+4,116
+47% +$411K 0.19% 172
2020
Q4 		$979K Buy
8,727
+358
+4% +$37.7K 0.14% 243
2020
Q3 		$776K Sell
8,369
-4,536
-35% -$349K 0.14% 227
2020
Q2 		$1.01M Buy
12,905
+7,644
+145% +$517K 0.2% 166
2020
Q1 		$308K Buy
5,261
+402
+8% +$25.9K 0.25% 144
2019
Q4 		$389K Sell
4,859
-6,432
-57% -$482K 0.06% 385
2019
Q3 		$830K Buy
11,291
+750
+7% +$64.8K 0.19% 157
2019
Q2 		$994K Buy
+10,541
New +$870K 0.19% 157

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Quantitative Systematic Strategies's BPMC Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Blueprint Medicines (BPMC) in Q3 2021, closing a stake of 5,990 shares — an estimated $527K sold.

Quantitative Systematic Strategies first reported a position in BPMC in Q2 2019 and held it in 9 quarters. The position peaked at $1.25M in Q1 2021. 288 funds tracked by Wall St. Rank hold BPMC as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining Blueprint Medicines position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 5,990 Blueprint Medicines shares in Q3 2021, an estimated $527K.
  • Quantitative Systematic Strategies first reported a position in Blueprint Medicines in Q2 2019 and held it in 9 quarters.
  • Quantitative Systematic Strategies's Blueprint Medicines position peaked at $1.25M in Q1 2021.
  • 288 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.